New Jersey: The Life Sciences Commercialization Hub

New Jersey: The Life Sciences Commercialization Hub2018-11-28T21:39:49+00:00

Monday, December 10, 2018

The Park Avenue Club

184 Park Avenue, Florham Park, NJ

10:30 am – 2:00 pm  (lunch will be served)

Registration: 10:30am

Panel: 11am-12:15am

Lunch & Keynote: 12:30pm—2:00pm

Register Today!

Join us to learn about New Jersey’s climate for commercialization!

Keynote Speaker

John Crowley
John CrowleyChairman and CEO of Amicus Therapeutics, inspiration for the movie “Extraordinary Measures” and NJ success story that grew his company from four employees to over 400.
John F. Crowley is the Chairman and CEO of Amicus Therapeutics. John’s involvement with biotechnology stems from the 1998 diagnosis of two of his children with Pompe disease—a severe and often fatal neuromuscular disorder. In his drive to find a cure for them, he left his position at Bristol-Myers Squibb and became an entrepreneur as the Co-founder, President and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease (which he credits as ultimately saving his children’s lives). In 2001, Novazyme was acquired by Genzyme Corporation and John continued to play a lead role in the development of a drug for Pompe disease as Senior Vice President, Genzyme Therapeutics.

John and his family have been profiled on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, “The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children.” The major motion picture, Extraordinary Measures, starring Brendan Fraser and Harrison Ford, is inspired by the Crowley family journey. John is the author of a personal memoir: Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy.

John is also a commissioned officer in the U.S. Navy Reserve, assigned to the United States Special Operations Command and is a veteran of the global war on terrorism, with service in Afghanistan. He graduated with a B.S. in Foreign Service from Georgetown University, and earned a J.D. from the University of Notre Dame Law School and an M.B.A. from Harvard. The Crowley family was the recipient of the 2011 Family Exemplar Award from the University of Notre Dame. He is also a member of the University Council on Science & Technology at Notre Dame. He is the National Chairman of the Make A Wish Foundation of America and is a founding Board member of the Global Genes Project. John is a Henry Crown Fellow at the Aspen Institute.

Morning Panel on New Jersey’s Climate for Commercialization

Dean J. Paranicas - MODERATOR
Dean J. Paranicas - MODERATORPresident and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ)
Dean J. Paranicas became the third president and chief executive officer of the HealthCare Institute of New Jersey (HINJ) in March 2011. Prior to joining HINJ, Mr. Paranicas was Vice President, Corporate Secretary and Public Policy for BD. Starting at BD in 1981, he previously served in various legal roles, and also as Director, Corporate Development and Strategic Investments, as Director, Investor Relations, and as Vice President, Investor Relations and Public Affairs.

Mr. Paranicas began his career as an associate attorney with McCarter & English, LLP in Newark, New Jersey. He earned a B.A. Degree With Honors from Rutgers College, Rutgers University, where he was a member of Phi Beta Kappa. He earned a J.D. degree from Rutgers-Newark School of Law, where he was an Editor of the Rutgers Law Review. Previously, Mr. Paranicas served as HINJ’s Board Secretary and Chair of its Steering Committee.

Deborah Collins Penza, Esq.
Deborah Collins Penza, Esq. SVP and Chief Compliance Officer at Melinta Therapeutics
Deborah is a dynamic executive leader with over 25 years of compliance management experience. She has substantial experience developing and implementing global compliance functions, and she is also highly skilled at identifying critical business issues and risks. Ms Collins has superior proficiency in all areas of compliance management in healthcare laws and regulations.
Hon. Christopher DePhillips
Hon. Christopher DePhillipsNJ State Assemblyman (R-40) and VP of Administration & General Counsel at Porzio Life Sciences
CHRISTOPHER P. DEPHILLIPS is Vice President of Administration and General Counsel of Porzio Life Sciences, LLC. In this role, Mr. DePhillips meets with life sciences companies to identify sales and marketing challenges and to propose solutions that streamline their practices in meeting compliance requirements of all 50 states and the District of Columbia.

Mr. DePhillips is also Vice President of Porzio Compliance Services, LLC. He works with health care companies to provide strategies and tools for their compliance and regulatory challenges.
Mr. DePhillips received a J.D. from Seton Hall University School of Law and a B.A. in Government-Comparative Politics from Georgetown University.

Scott Miller
Scott MillerExecutive Director of Global Compliance at Syneos Health
Scott Miller is responsible for Commercial Compliance in the United States, Europe and Asia. Commercial Compliance is responsible for our Selling Solutions field services, Communications Companies, Advertising agencies and Public Relations Firms, Patient Outcomes, and the Consulting group.
Christine Mikail
Christine MikailPresident and Co-Founder of Neumentum
hristine has spent 15 years in the biopharma industry serving in a variety of roles spanning corporate strategy and business development, managing and building operations at start-up companies and constructing and executing on complex financings and life sciences transactions.

Christine served as CAO, head of external business development and general counsel of Axovant Sciences, Inc., which is developing solutions for patients with dementia. Christine was part of the small leadership team of five that took Axovant public in 2015 with a $362 million IPO, the largest biotech IPO in history at the time. Christine built operations from the ground up and led business development at this fast-growing company.

Prior to that, she was senior vice president for legal affairs, general counsel and board secretary at NPS Pharmaceuticals, Inc., where she was an integral part of its sale to Shire Pharmaceuticals for $5.2 billion. Christine also was executive vice president for corporate development at the Dendreon Corporation, where she led the company’s restructurings that culminated in its sale to Valeant.

Hon. Steve Oroho
Hon. Steve Oroho
Senator Steve Oroho is currently serving his fourth term in the New Jersey State Senate. He represents the 24th Legislative District in the northwestern part of the state which comprises all of Sussex County, and parts of northern Warren and Morris counties.

Before entry into public office, Senator Oroho had extensive professional experience in the finance departments of top New York City firms, including work for Price Waterhouse, W.R. Grace and Company, as well as Young and Rubicam where he held the position of Senior Vice President of Finance. Senator Oroho is presently a certified financial planner with Stonebridge Capital Management.

Senator Oroho first ran for public office in 2001 winning a seat on the Franklin Borough Council. He moved up to the Sussex County Freeholder Board in 2005 upon his successful election and served one term before winning election to the State Senate in 2007, and has twice been re-elected.

Download Flyer Here